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Abstract
Background: Torque teno virus (TTV) is a circular, single-stranded DNA virus that chronically
infects healthy individuals of all ages worldwide. There is a lot of data on the prevalence and genetic
heterogeneity of TTV in healthy populations and in patients with various diseases now available.
However, little is known about TTV load among healthy human population. In this study we
analyzed TTV load in the group of 512 Russian elite athletes, who are supposed to be, by some
standards, the healthiest part of the human population.
Results: The prevalence rate of TTV among the Russian Olympic Reserve members was 94% (for
test sensitivity about 1000 genome equivalents per 1 ml of blood). Quantities varied from 103
(which corresponded to detection limit) to 1010 copies per 1 ml of blood, with median at 2.7 × 106
copies.
Conclusion: About 94% of healthy individuals in Russian population have more than 1000 TTV
genome copies per 1 ml of blood. This result exceeds the previously published data, and can be
explained by either more sensitive PCR test system or by higher TTV distribution in Russian
population or both. TTV viral load neither depends on gender, nor age.
Background
Torque teno virus (TTV) was first discovered in 1997 in
Japanese patients with non-A-G transfusion-acquired hep-
atitis [1]. TTV is a small, non-enveloped virus with a sin-
gle-stranded, circular DNA genome of negative polarity,
3.4-3.9 Kb in length, containing two bigger (ORF1 and
ORF2) and several smaller open reading frames [2]. TTV is
currently classified to Circoviridae family [2]. Despite
being a DNA virus, TTV demonstrates an extremely wide
sequence divergence. At least 16 genotypes with evolu-
tionary distance >0.30 has been described so far [3].
TTV is an ubiquitous virus revealed in more than 50% of
the general human population throughout the world [4-
6] and nearly 90% of pongid populations [7]. Co-infec-
tion of single individuals with TTV isolates belonging to
one or several phylogenetic groups occurs frequently [8].
TTV was first characterized as a blood-born virus and thus
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referred to transfusion-transmitted (TT) group of viruses
[1]. Recent studies suggested the existence of other ways of
transmission including parenteral [3], sexual [9,10],
mother-to-child [11,12] and others [13-15].
TTV has been suggested to be a causative agent of several
diseases such as acute respiratory diseases [16], liver dis-
eases [5,6], AIDS [17] and cancer [18], however, without
any convincing support. One of current hypothesis sug-
gests a key role of TTV in development of autoimmune
reactions [19].
Despite 10 years of investigation, the TTV distribution in
humans is still a subject of discussion. Possibly, this is
because of the variability of TTV genotypes and the inabil-
ity to design a single set of PCR primers, corresponding to
the vast majority (if not all) viral genotypes [20]. Also lit-
tle is known about distribution of TTV in healthy adults
[21,22]. In this study we analyzed TTV viral load in blood
of 512 Russian elite athletes who represents healthy Rus-
sian population.
Results
Using qPCR we demonstrated that 485 out of 512 (94%)
healthy individuals have TTV viral load of more than 1000
copies per 1 ml of blood, which corresponds to 94.1% of
males and 93.9% of females studied. Considerable part of
the athletes (39.9%) had viral load about 106 copies per 1
ml of blood (median 2.7 × 106) with maximum about
1010 viral genomes per 1 ml (see Fig. 1).
We failed to detect any correlation between the viral load
and the age of tested individuals (R = 0.020; p > 0.05).
Also no difference was detected in viral load for men and
women (independent t-test: t-value = -1.943; p = 0.052).
Discussion
Discovered frequency of TT virus presence in top rank Rus-
sian athletes exceeds the previously published data for
healthy human populations (14-88%) [1-6,15,16,21].
The difference may be explained by wider distribution of
TTV in Russians and/or more sensitive PCR test system,
which detects more TTV variants. The latter idea is sup-
ported by the fact that the frequency of TTV in popula-
tions detected in the recent studies is higher than in the
early studies, which probably can be explained by the
application of more accurate methods for TTV detection.
In fact, the TTV genome has estimated sequence diver-
gence of more than 30% [15], and the minority of meth-
ods used so far were able to detect all the TTV variants.
Expansion of the TTV sequencing data enabled us to
design primers corresponding to the most constant sites
in the TTV genome.
Our PCR test system has calculated sensitivity about 1000
viral genomes per ml of blood. Thus, all the samples with
the less viral load were considered as negative. Our data
may suggest that the real frequency of TTV presence in
human population tends to be close to 100%.
Conclusion
TTV viral load of more than 1000 copies per 1 ml of blood
was detected for 94% of Russian elite athletes. Maximum
viral load was about 1010, median was 2.7 × 106. There
were no significant differences between men and women.
Also viral load did not seem to be dependent on age (in
the range of this study). In general, the presence of TTV in
healthy human population was higher than it has been
previously described in literature. This fact can be
explained by the higher presence of TTV among Russian
population and/or by more sensitive PCR test system
used. The absence of correlation between the age and the
viral load supports the previously published data.
Methods
Samples and DNA purification
We analyzed the venous blood of 205 men and 232
women of Russian elite athletes aged between 12 and 36.
All samples were stored less than three hours at +4°C
before analysis. DNA was extracted from blood samples
by standard phenol-chloroform extraction [23]. To pre-
vent PCR contamination by blood samples or DNA sam-
ples, DNA isolation was performed in a separate DNA-
extraction room (Zone 1). To prevent samples cross-con-
tamination, all the procedures were carried out with ster-
ile disposable tubes and aerosol-resistant tips in UV-
equipped PCR-box.
Viral load of TTV among studied samples Figure 1
Viral load of TTV among studied samples. The histo-
gram shows distribution of viral load among studied samples. 
Numbers above each bar represent number of samples.Virology Journal 2009, 6:134 http://www.virologyj.com/content/6/1/134
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Primer and probe design and sequences
The primers and the probe for PCR were designed using
the Oligo Primer Analysis software v6.31 (Molecular Biol-
ogy Insights Inc., USA) and mfold v3.1 [24] based on
alignment of different TTV genome sequences (GenBank,
[25]). The set of primers used in this study amplify all
known TTV variants (for primer and probe sequences see
Table 1).
qPCR
qPCR was used for detection and quantification of TTV
load. For each PCR sample contained 1-μl-blood equiva-
lent, we may estimate test sensitivity as 1000 viral copies
per 1 ml of blood (with PCR sensitivity of 1 target per PCR
tube).
PCR was carried out in reaction volumes of 35 μL with 80
mM Tris-HCl pH 8.6, 20 mM (NH4)2SO4, 3 mM MgCl2,
200 μM of each dNTP, 300 nM of each primer, 75 nM of
probe and 2.0 U of Taq-polymerase. Real-Time PCR was
performed using DT-96 Real-Time PCR Cycler (DNA-
Technology, Russia) with the first denaturation step of 60
s at 94°C, followed by 50 cycles at 94°C for 10 s, 64°C for
20 s, 72°C for 10 s, with fluorescence reading at 64°C.
The delta-TF method was used for curve normalization
[26] and ΔΔCp for quantification. Human MTHFR gene
was used for DNA amount standardization.
To prevent PCR contamination by previous reactions nor
biological samples, all the reactions were combined using
aerosol-resistant tips in UV-equipped PCR-box in a sepa-
rate PCR-preparation room (Zone 2). Also, no electro-
phoresis (or other procedures with PCR-tube opening)
was done with TTV PCR primers in this building. All the
negative controls and surface washings were negative.
Data analysis
PCR data was analyzed using DT-96 Real-Time PCR Cycler
Software v.7.2 (DNA-Technology, Russia). Statistica 8.0
(StatSoft, USA) was used for statistical analysis.
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